KFAS
BBH icon

Keating Financial Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Keating Financial Advisory Services’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$1.51K – 2576
2025
Q4 		$1.51K Buy
+8
New +$1.48K ﹤0.01% 1672

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Keating Financial Advisory Services's BBH Position: Q1 2026 in Review

Keating Financial Advisory Services sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 8 shares — an estimated $1.51K sold.

Keating Financial Advisory Services first reported a position in BBH in Q4 2025 and held it in 1 quarter. The position peaked at $1.51K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Keating Financial Advisory Services reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • Keating Financial Advisory Services sold 8 VanEck Biotech ETF shares in Q1 2026, an estimated $1.51K.
  • Keating Financial Advisory Services first reported a position in VanEck Biotech ETF in Q4 2025 and held it in 1 quarter.
  • Keating Financial Advisory Services's VanEck Biotech ETF position peaked at $1.51K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.